曲安奈德联合甲氨喋呤关节腔注射治疗类风湿关节炎

目的探讨联合使用甲氨喋呤(MTX)和曲安奈德(TA)关节腔注射治疗类风湿关节炎(RA)的疗效。方法选择2006年1月-2007年4月我院门诊对称性腕或膝关节炎的RA患者37例。选择一对炎症程度相当的膝或腕关节,随机确定一侧,以曲安奈德针(TA)1mL:40mg溶解MTX针(MTX)5mg混匀后关节腔注射(TM组)。对侧作为对照,以相同剂量曲安奈德针关节腔注射(TA组),整体治疗不变,继续按原来方法服用NSAIDs及DMARDs治疗。分别于注射后第1个月、3个月、6个月末观察注射关节的肿胀数、疼痛数、压痛数及相应指数。结果TM组与TA组关节腔注射后,肿胀关节明显减少,而不同时间点两组间差异均有统计学意义(P<0.01)。随访6个月,两组均未发现明显不良反应。结论曲安奈德针联合MTX针关节腔注射治疗类风湿关节炎,其消炎、止痛、消肿和改善患者关节功能的疗效优于单用曲安奈德针关节腔注射,可显著减少复发机会,延迟复发时间,是类风湿关节炎有效的控制方法之一。     

曲安奈德注射加针刀松解治疗肩周炎

目的:探索治疗肩周炎的重要方法.方法:应用曲安奈德40 mg、2%利多卡因5ml行痛点注射,再利用针刀松解后手法活动肩关节.1～2周后可重复.结果:本组治疗157例,治愈126例(80.25%),显效27例(17.20%),好转4例(2.55%),无效0例(0),总有效率达到100.00%.结论:曲安奈德注射加针刀松解治疗肩周炎是一种特别有效的重要方法.安全可靠,临床操作方便.     

XH超高频皮肤整形手术仪联合曲安奈德注射液治疗女阴汗管瘤14例临床观察

目的观察XH超高频皮肤整形手术仪联合曲安奈德注射液治疗女性外阴部汗管瘤的临床疗效。方法将曲安奈德注射液和利多卡因注射液混匀后,在14例女性外阴部汗管瘤皮损局部注射,再用XH超高频皮肤整形手术仪清除瘤体。术后随访6个月。结果痊愈12例,显效2例,有效率为100%。结论 XH超高频皮肤整形手术仪联合曲安奈德注射液治疗女性外阴部汗管瘤疗效好,不良反应少。     

A prospective,randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis

Background Topical aloe vera (AV) has been used to treat various skin conditions, including psoriasis, with good results. Objectives This study aims to compare the efficacy of AV and 0.1% triamcinolone acetonide (TA) in mild to moderate plaque psoriasis. Methods A randomized, comparative, double‐blind, 8‐week study was designed. Eighty patients randomly received AV or 0.1% TA cream and their clinical response were evaluated using the Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI). Results After 8 weeks of treatment, the mean PASI score decreased from 11.6 to 3.9 (–7.7) in the AV group and from 10.9 to 4.3 (–6.6) in the TA group. Between‐group difference was 1.1 (95% confidence interval –2.13, –0.16, P = 0.0237). The mean DLQI score decreased from 8.6 to 2.5 (–6.1) in the AV group and from 8.1 to 2.3 (–5.8) in the TA group. Between‐group difference was 0.3 (95% confidence interval –1.18, –0.64, P = 0.5497). There was no follow‐up period after the 8‐week treatment. Conclusions AV cream may be more effective than 0.1% TA cream in reducing the clinical symptoms of psoriasis; however, both treatments have similar efficacy in improving the quality of life of patients with mild to moderate psoriasis.     

Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars

While treatment of keloids and hypertrophic scars normally shows modest results, we found that treatment with bleomycin was more promising. The present study was divided into two parts. In the first part the aim was to show the results using a combination of bleomycin and triamcinolone acetonide per cm² (BTA). In the second part the objective was to determine the response to both drugs in large keloids that were divided into 1 cm² squares, treating each square with the dose previously used. In the first part of the study, the clinical response of 37 keloids ranging from 0.3 to 1.8 cm² treated with BTA were followed up over a period of 1- 2 years. 0.375 IU bleomycin and 4 mg triamcinolone acetonide were injected every 3 months. In the second part of the study we reviewed the clinical response in six patients with large keloids. The monthly dose administered never exceeded 3 IU of bleomycin. The first study showed 36 keloids (97.29%) softening after the first dose. In the second study, 5 showed different responses (the response was complete in the four smaller keloids). The largest keloid needed 9 doses to achieve an improvement of 70%. In conclusion, combined treatment with 0.375 IU of bleomycin and 4mg of triamcinolone acetonide to 1 cm² was considered to be an acceptable procedure for the treatment of keloids. The best results were obtained in keloids over 1 cm² or when divided into 1 cm² square areas. Larger series need to be performed in order to confirm these results..     

曲安奈德玻璃体内注射治疗黄斑水肿对眼压的影响观察

目的:评价曲安奈德玻璃体内注射治疗糖尿病性黄斑水肿在眼压方面的安全性。方法:将双眼糖尿病性黄斑水肿患者分别采用4m g和8m g不同剂量的曲安奈德玻璃体内注射,观察最佳矫正视力维持时间和眼压升高情况的差异。结果:两种剂量的曲安奈德玻璃体内注射均可使黄斑水肿消退,最佳矫正视力维持时间两组有显著性差异(P<0.05),4m g和8m g两种剂量曲安奈德玻璃体内注射引起眼压升高无显著性差异(P>0.05)。结论:4m g和8m g曲安奈德玻璃体内注射均可引起眼压升高,可尝试应用8m g剂量替代4m g曲安奈德玻璃体内注射以维持最佳矫正视力和减少玻璃体内注射次数带来的风险。     

RP-HPLC法同时测定复方曲安奈德乳膏中醋酸曲安奈德和硝酸咪康唑的含量

目的建立同时测定复方曲安奈德乳膏中醋酸曲安奈德和硝酸咪康唑含量的方法。方法采用RP-HPLC法。色谱柱为SunFire C18柱,流动相为甲醇-水(70∶30),检测波长为230nm,流速为1.0mL.min-1,柱温为30℃。结果醋酸曲安奈德和硝酸咪康唑质量浓度分别在0.008 4～0.050 4mg.mL-1(r=0.999 7)和0.049 8～0.298 8mg.mL-1(r=0.9998)范围内与峰面积积分值线性关系良好。平均回收率分别是98.3%,RSD为1.6%(n=9);98.6%,RSD为1.5%(n=9)。结论该方法准确、方便、快速,可用于复方曲安奈德乳膏中醋酸曲安奈德和硝酸咪康唑含量的测定。     

Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery

AIM: To do a randomized prospective interventional study for comparing the effects of a single subconjunctival triamcinolone acetonide (SCTA) injection to tapering topical loteprednol in patients undergoing phacoemulsification surgery under topical anesthesia. METHODS: A total of 400 patients were randomized into 2 groups; Group A (200 patients) received 5 mg SCTA at the end of surgery and topical ketorolac tromethamine (0.5%) with ofloxacin (0.3%) combination for 3wk. Group B (200 patients) received tapering topical loteprednol etabonate (0.5%) along with ofloxacin (0.3%) and ketorolac tromethamine (0.5%) for 3wk. Outcomes evaluated were intraocular pressure (IOP), anterior chamber cells/flare and macular oedema postoperatively at 1, 6 and 12wk. RESULTS: Baseline parameters were almost similar in both the groups. No statistical difference was seen between the preoperative and postoperative IOP values for Group A (P=0.82) and Group B (P=0.61) and postoperative IOP values in between both groups (P=0.14) at 1wk. Incidence of cells/flare postoperative was statistically not significant (P=0.82) in both groups at all follow up visits. Postoperative macular oedema was not observed at any follow up visit. CONCLUSION: SCTA appears to be an effective alternative to prolong postoperative topical steroid use.     

鼓室注射桉柠蒎肠溶软胶囊联合曲安奈德治疗分泌性中耳炎疗效分析

目的：探讨鼓室注射桉柠蒎肠溶软胶囊联合曲安奈德治疗分泌性中耳炎的疗效。方法将105例（137耳）诊断为分泌性中耳炎的患者随机分为观察组（52例,68耳）与对照组（53例,69耳）,患者在治疗前后均行纯音听阈及声导抗检测。二组患者均给予口服大环内酯类药物2周,曲安奈德喷鼻4周。观察组患者同期给予鼓膜穿刺抽出鼓室积液后鼓室内注射桉柠蒎肠溶软胶囊联合曲安奈德。对照组患者给予鼓膜穿刺抽出鼓室积液后鼓室内注射地塞米松。结果观察组总有效率89．71％高于对照组66．67％。观察组纯音听阈改善率为86．76％明显高于对照组改善率57．97％（ P＜0．05）;声导抗检测改善率为92．65％,明显高于对照组改善率63．77％（ P＜0．05）,差异有统计学意义。结论鼓室注射桉柠蒎肠溶软胶囊联合曲安奈德治疗分泌性中耳炎的方法疗效肯定。